Table 3.

Characteristics of the 24 patients with combined glucocorticoid and mineralocorticoid residual production

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20	21	22	23	24
S-F, nM	340	311	277	230	228	225	204	164	156	128	123	120	106	98	91	82	81	71	54	43	43	36	22	19
S-S, nM	2.2	2.1	1.1	1.9	1.4	2.9	1.9	1.7	2.4	1.1	0.8	1.4	2.4	1.0	1.0	0.7	0.7	1.1	0.2	0.6	2.7	0.2	0.2	0.1
S-Aldo, pM	217	69	135	121	56	25	14	15	86	104	39	39	15	92	53	28	29	51	66	31	24	38	10	33
S-CCN, nM	51	25	39	38	7	13	13	17	15	9	18	8	6	4	9	9	3	4	4	4	2	2	2	2
Sex, M or F	F	M	F	F	M	F	M	F	F	F	M	F	F	F	F	F	M	F	F	M	F	M	M	F
Age, years	23	63	32	43	62	51	18	47	40	59	30	53	55	51	49	53	18	45	66	26	23	38	36	42
DD, years	5	6	1	5	26	9	5	7	0.5	6	4	24	9	20	5	1	2	7	2	2	1	21	7	12
AC, yes or no	yes	yes	no	yes	yes	no	yes	yes	yes	no	yes	yes	no	no	yes	no	yes	no	yes	yes	no	no	yes	yes
HCeq., mg	20	25	20	20	20	10	28	30	30	20	25	20	15	10	17.5	20	30	20	20	40	30	30	30	25
BMI, kg/m 2	18.1	25.6	24.4	23.0	26.1	23.3	27.8	29	34.3	37.1	28.7	27.1	26.0	25.9	27.8	29.4	20.8	22	21.0	21.2	22.0	26.5	22.3	18.8
AddiQoL score	66	89	72	102	94	95	90	105	73	117	86	80	93	95	80	96	102	101	93	99	83	91	*	91
P-ACTH, pmol/L	63	32	26	70	34	68	39	210	62	237	82	67	120	134	88	259	224	225	31	278	125	43	278	175
PRC, mU/L	500	187	146	302	48	308	76	325	122	124	179	22	*	465	61	337	77	107	22	152	350	214	81	915

Abbreviations: AAD, autoimmune Addison disease; AC, adrenal crisis ever; AddiQoL, AAD-specific questionnaire; BMI, body mass index; DD, disease duration; F, female; HCeq, hydrocortisone-equivalent dose; M, male; P-ACTH, plasma adrenocorticotropic hormone; PRC, plasma renin concentration; S-Aldo, serum aldosterone; S-CCN, serum corticosterone S-F, serum cortisol, S-S, serum 11-deoxycortisol.

* Not obtained.